Ackman Adds Exposure As Valeant Responds to CitronMark Melin
Valeant stock rebounded in the afternoon, aided in part by an announcement by the firm categorizing Citron’s research as erroneous and an announcement by one of their largest shareholders, William Ackman, that he had bought the stock while blood was on the street.
Ackman gets behind his Valeant exposure after a rough day
As Valeant stock was trading down at $88.58 around at 1:35 PM Eastern Time, and Pershing Square’s loss on the day was just over $1.1 billion, William Ackman . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible